Bibliometric and visualized analysis of mitophagy in liver cancer from 1998 to 2024
Discover Oncology · 06.07.2025 · 16 (1)
DOI: 10.1007/s12672-025-03098-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Discover Oncology, online erschienen am 06.07.2025. Verfasst von Shanshan Gong und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, 310005, Zhejiang, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Basic Public Welfare Research Program of Zhejiang Province, Zhejiang Traditional Chinese Medicine Administration.
Abstract (Originalsprache)
BACKGROUND: Mitophagy is crucial for maintaining mitochondrial homeostasis and the internal environment of the liver. It plays a dual role in the emergence and progression of liver cancer by removing damaged mitochondria and supplying energy. Additionally, mitophagy can influence the effectiveness of liver cancer treatments through various signaling pathways. AIM: This study aims to summarize the research status, hot spots, frontiers, and development trends of mitophagy in liver cancer based on bibliometrics and visual analysis. METHODS: Publications on mitophagy in liver cancer were searched in the Web of Science Core Collection (WoSCC) database as of December 11, 2024. Vosviewer, Co-Occurrence software, CiteSpace, and SCImago Graphica were utilized for bibliometric and visualized analysis. RESULTS: We collected 703 publications from WoSCC. Over the past 27 years, the number of publications on mitophagy in liver cancer has shown a consistent upward trend. China leads in the number of publications and total citations. Notable institutions contributing significantly to this field include Zhejiang University, the Chinese Academy of Sciences, and Sun Yat-sen University. Key journals for publishing research on mitophagy in liver cancer are the International Journal of Molecular Sciences, Frontiers in Oncology, and Autophagy. Major contributors to this area of study include Wang Bin and Li Yan. In recent years, the mechanisms associated with mitophagy and liver cancer have remained a hot spot, including ferroptosis, aerobic glycolysis, transcription factor EB, mitochondrial dysfunction, and oxidative stress. In addition, combining sorafenib with melatonin may present a promising therapeutic option for advanced liver cancer. CONCLUSION: This is the first comprehensive and in-depth bibliometric study of trends and developments of mitophagy in liver cancer. It provides researchers with panoramic knowledge of this field, as well as research hotspots and future directions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, The Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, 310005, Zhejiang, China.
- Department of Integrated Chinese and Western Medicine, The First People's Hospital of Jiashan, Jiashan Hospital affiliated of Jiaxing University, Jiaxing, 314100, Zhejiang, China. feiyuchang123456@163.com.
Förderung
- Basic Public Welfare Research Program of Zhejiang Province
- Zhejiang Traditional Chinese Medicine Administration
Zitieren
APA
Gong, S., & Fei, Y. (2025). Bibliometric and visualized analysis of mitophagy in liver cancer from 1998 to 2024. Discover Oncology, 16(1). https://doi.org/10.1007/s12672-025-03098-7
Vancouver
Gong S, Fei Y. Bibliometric and visualized analysis of mitophagy in liver cancer from 1998 to 2024. Discover Oncology. 2025;16(1). doi:10.1007/s12672-025-03098-7
BibTeX
@article{Gong2025,
author = {Gong, Shanshan and Fei, Yuchang},
title = {Bibliometric and visualized analysis of mitophagy in liver cancer from 1998 to 2024},
journal = {Discover Oncology},
year = {2025},
volume = {16},
number = {1},
doi = {10.1007/s12672-025-03098-7}
}
EUVIMED